Cell Valley provides R&D and outsourcing production services for
CAR-T cells with different targets, and the retroviral vector of cell valley is used for preparation. At present, many
CAR-T cells targeting CD19, CD38, BCMA-CD38 and other double targets have been successfully prepared using the independently produced retroviral vector.